biotech & pharma

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and…

Veru Inc (NASDAQ:VERU) Q2 2023 Earnings Call dated May. 11, 2023. Corporate Participants: Samuel Fisch -- Executive Director of Investor Relations and…

PetIQ, inc (NASDAQ: PETQ) Q1 2023 Earnings Call dated May. 09, 2023 Corporate Participants: Katie Turner -- Investor Relations Cord…

Merck & Co., Inc. (NYSE: MRK) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Peter Dannenbaum -- Vice President, Investor…

RVL Pharmaceuticals plc (NASDAQ: RVLP) Q4 2022 earnings call dated Mar. 20, 2023 Corporate Participants: Lisa Wilson -- Investor Relations Brian Markison -- Chief…

Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2022 Earnings Call dated Feb. 28, 2023. Corporate Participants: Atabak Mokari -- Chief Financial Officer Charles Robb -- Chief…

PetIQ Inc (NASDAQ:PETQ) Q4 2022 Earnings Call dated Feb. 28, 2023. Corporate Participants: Katie Turner -- Investor Relations McCord Christensen -- Chief Executive Officer…

Moderna Inc (NASDAQ:MRNA) Q4 2022 Earnings Call dated Feb. 23, 2023. Corporate Participants: Lavina Talukdar -- Head of Investor Relations Stephane Bancel -- Chief…

Merck & Co Inc (NYSE:MRK) Q4 2022 Earnings Call dated Feb. 02, 2023. Corporate Participants: Peter Dannenbaum -- Vice President, Investor Relations…